Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 166–180 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2276 COL2A1 Gene Spondyloperipheral Dysplasia Genetic Test This genetic test identifies pathogenic variants within the COL2A1 gene, which are associated with spondyloperipheral dysplasia.	Whole Blood, Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COL2A1 gene"] Parameters [] Preparation ["No special preparation required", "A prior genetic counselling session to draw a pedigree chart is mandatory"] Indications ["Suspected spondyloperipheral dysplasia", "Differential diagnosis of skeletal dysplasias", "Family planning for inherited conditions"] Measurement technique Confirm with laboratory Codes LOINC: 81257-1 ICD-10: Q77.8 Clinical summary This genetic test identifies pathogenic variants within the COL2A1 gene, which are associated with spondyloperipheral dysplasia.
TEST-2402 COL4A1 Gene Porencephaly, Familial Genetic Test This test evaluates the COL4A1 gene for pathogenic variants associated with familial porencephaly and cerebral small vessel disease.	Peripheral Whole Blood, FTA Card, or Extracted DNA	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COL4A1 gene", "Point mutations", "Small indels", "Exon-level copy number variants"] Parameters [] Preparation [] Indications ["Individuals with personal or family history of early-onset stroke", "Individuals with personal or family history of brain cysts", "Individuals with personal or family history of developmental delay", "Suspected familial porencephaly", "Cerebral small vessel disease"] Measurement technique Confirm with laboratory Codes LOINC: 49990-2 ICD-10: Q04.6 Clinical summary This test evaluates the COL4A1 gene for pathogenic variants associated with familial porencephaly and cerebral small vessel disease.
TEST-5170 COL5A1 Gene Ehlers-Danlos Syndrome Type 1/2 Genetic Test This test identifies pathogenic variants in the COL5A1 gene to confirm a molecular diagnosis of Classical Ehlers-Danlos Syndrome (Type 1/2).	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COL5A1 gene", "Copy Number Variations (CNV) in COL5A1"] Parameters [] Preparation ["No special preparation such as fasting is required.", "Complete a comprehensive clinical history form.", "Participate in a mandatory genetic counselling session for familial pedigree charting."] Indications ["Clinical suspicion of Classical Ehlers-Danlos Syndrome (cEDS)", "Confirmation of cEDS diagnosis", "Genetic counseling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 90207-0 ICD-10: Q79.6 Clinical summary This test identifies pathogenic variants in the COL5A1 gene to confirm a molecular diagnosis of Classical Ehlers-Danlos Syndrome (Type 1/2).
TEST-4261 COL6A3 Gene DYT27 Genetic Test This test evaluates the entire coding region of the COL6A3 gene for pathogenic variants associated with autosomal dominant dystonia type 27 (DYT27).	Whole Blood (EDTA), Extracted DNA (≥1 µg), or FTA Card Blood Spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COL6A3 gene"] Parameters [] Preparation [] Indications ["Suspected autosomal dominant dystonia type 27 (DYT27)", "Inconclusive prior neurological evaluations for dystonia"] Measurement technique Confirm with laboratory Codes LOINC: 79371-8 ICD-10: G24.1 Clinical summary This test evaluates the entire coding region of the COL6A3 gene for pathogenic variants associated with autosomal dominant dystonia type 27 (DYT27).
TEST-442 Combined Whole Exome Sequencing (WES) and Chromosomal Microarray (CMA) Test This test evaluates the entire protein-coding region of the genome (exome) and chromosomal copy number variations (CNVs) simultaneously.	Peripheral whole blood (EDTA) – 3–5 mL	14–21 calendar days	5,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single-nucleotide variants", "Indels", "Copy Number Variations (CNVs)", "Regions of Homozygosity (AOH)"] Parameters [{"name": "Methodology", "reference_range": "NGS (Illumina NovaSeq) Exome Capture + Affymetrix CytoScan HD Array"}, {"name": "Resolution", "reference_range": "Single-nucleotide variants, indels, CNVs ≥25 kb, AOH regions"}, {"name": "Diagnostic Yield (Neurodevelopmental)", "reference_range": "~45–50%"}] Preparation ["No fasting required", "Inform nursing team if taking blood-thinning medications", "Inform genetic counsellor of recent blood transfusions or allogeneic bone marrow transplants"] Indications ["Paediatric neurodevelopmental delay", "Dysmorphic syndromes", "Hereditary cancer predisposition", "Global developmental delay", "Multiple congenital anomalies"] Measurement technique Confirm with laboratory Codes LOINC: 81247-2 ICD-10: Z13.79, Q99.9, Z15.09 Clinical summary This test evaluates the entire protein-coding region of the genome (exome) and chromosomal copy number variations (CNVs) simultaneously.
TEST-5132 COMP Gene Epiphyseal Dysplasia, Multiple, Type 1 Genetic Test This genetic test identifies pathogenic variants in the COMP gene associated with Multiple Epiphyseal Dysplasia Type 1 (MED1).	Whole blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["COMP gene coding region", "Pathogenic variants"] Parameters [] Preparation [] Indications ["Symptomatic patients", "At-risk family members", "Proactive genetic screening"] Measurement technique Confirm with laboratory Codes LOINC: 21567-2 ICD-10: Q77.7 Clinical summary This genetic test identifies pathogenic variants in the COMP gene associated with Multiple Epiphyseal Dysplasia Type 1 (MED1).
TEST-4641 COMP Gene Pseudoachondroplasia Genetic Test This test evaluates the entire COMP gene for mutations associated with pseudoachondroplasia.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["COMP gene mutations", "Single nucleotide variants", "Insertions", "Deletions", "Copy number variations"] Parameters [] Preparation [] Indications ["Diagnostic confirmation of pseudoachondroplasia"] Measurement technique Confirm with laboratory Codes LOINC: 21635-2 ICD-10: Q77.3 Clinical summary This test evaluates the entire COMP gene for mutations associated with pseudoachondroplasia.
TEST-1750 Congenital Adrenal Hyperplasia (CAH) Full Gene Sequence Analysis Test This test performs full-gene sequencing of the CYP21A2 gene to identify mutations causing Congenital Adrenal Hyperplasia (CAH).	Peripheral whole blood (3–5 mL in EDTA lavender-top tube); alternative: extracted genomic DNA (2 µg minimum)	4–5 weeks	2,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CYP21A2 gene sequence", "Pathogenic variants", "Copy number variants"] Parameters [] Preparation ["No fasting required", "No medication adjustment necessary", "Inform physician about current corticosteroid use", "Valid doctor's prescription required (except for approved exemptions)", "Informed consent must be signed"] Indications ["Neonatal screening follow-up", "Ambiguous genitalia", "Salt-wasting crises", "Precocious puberty in boys", "Hirsutism with oligomenorrhea in females", "Carrier testing in at-risk relatives", "Pre-surgical clearance", "Pregnancy-related screening", "Travel abroad"] Measurement technique Confirm with laboratory Codes LOINC: 21631-4 ICD-10: E25.0, E25.8, E25.9 Clinical summary This test performs full-gene sequencing of the CYP21A2 gene to identify mutations causing Congenital Adrenal Hyperplasia (CAH).
TEST-706 Connexin 26 Mutation Detection Test This test identifies pathogenic variants in the GJB2 gene, the most common genetic cause of congenital sensorineural hearing loss.	Whole blood (4 mL lavender-top EDTA tube)	13 working days (sample by 11 am Saturday)	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the GJB2 gene", "Connexin 26 protein encoding sequence"] Parameters [] Preparation [] Indications ["Diagnosis of congenital sensorineural hearing loss", "Carrier screening for prospective parents", "Prenatal diagnosis (with CVS or amniocentesis)", "Genetic counseling for families with hearing loss"] Measurement technique Confirm with laboratory Codes LOINC: 21679-8 ICD-10: H90.3 Clinical summary This test identifies pathogenic variants in the GJB2 gene, the most common genetic cause of congenital sensorineural hearing loss.
TEST-700 Connexin 30 (GJB6) Mutation Detection Test This test detects pathogenic variants in the GJB6 gene, a common cause of congenital deafness.	Whole blood	10 working days	1,100.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GJB6 gene deletions", "GJB6 gene sequence variants"] Parameters [] Preparation [] Indications ["Newborns with failed OAE screening", "Children with delayed speech", "Adults with familial deafness"] Measurement technique Confirm with laboratory Codes LOINC: 21663-7 ICD-10: H90.3 Clinical summary This test detects pathogenic variants in the GJB6 gene, a common cause of congenital deafness.
TEST-5811 COQ8A Gene Spinocerebellar Ataxia Type 9 (Autosomal Recessive) Genetic Test This genetic test identifies pathogenic variants in the COQ8A gene associated with autosomal recessive spinocerebellar ataxia type 9 (SCAR9).	Whole blood (EDTA) or FTA card (finger-prick)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COQ8A gene", "Presence of mutations causing SCAR9"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Clinical suspicion of autosomal recessive spinocerebellar ataxia type 9 (SCAR9)", "Family history of SCAR9", "Progressive cerebellar ataxia of unknown origin"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: G11.1, G11.8, E71.540 Clinical summary This genetic test identifies pathogenic variants in the COQ8A gene associated with autosomal recessive spinocerebellar ataxia type 9 (SCAR9).
TEST-3584 COQ8B Gene Nephrotic Syndrome Type 9 Genetic Testing (NGS) Test This test detects pathogenic variants in the COQ8B gene associated with steroid-resistant nephrotic syndrome.	Peripheral whole blood (5 mL EDTA)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COQ8B gene"] Parameters [] Preparation [] Indications ["Diagnosis of steroid-resistant nephrotic syndrome type 9", "Familial screening for COQ8B variants", "Guiding targeted management"] Measurement technique Confirm with laboratory Codes LOINC: 21633-8 ICD-10: N04.9 Clinical summary This test detects pathogenic variants in the COQ8B gene associated with steroid-resistant nephrotic syndrome.
TEST-3421 CORIN Gene Preeclampsia/Eclampsia Type 5 Genetic Test This genetic test identifies pathogenic variants in the CORIN gene associated with an increased risk of developing severe, early-onset preeclampsia type 5 during pregnancy.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CORIN gene", "Disruption of atrial natriuretic peptide conversion"] Parameters [] Preparation ["Genetic counselling session required prior to sample collection", "No fasting required"] Indications ["Assessment of genetic risk for severe, early-onset preeclampsia type 5", "Guiding antenatal surveillance strategies"] Measurement technique Confirm with laboratory Codes LOINC: 95382-6 ICD-10: O14.9, O15.0, Z15.89 Clinical summary This genetic test identifies pathogenic variants in the CORIN gene associated with an increased risk of developing severe, early-onset preeclampsia type 5 during pregnancy.
TEST-4312 COX10 Gene Genetic Test for Mitochondrial Encephalopathy with Proximal Renal Tubulopathy This genetic test evaluates the COX10 gene for pathogenic variants associated with mitochondrial encephalopathy and proximal renal tubulopathy.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the COX10 gene", "Single nucleotide changes", "Small insertions/deletions", "Copy number alterations"] Parameters [] Preparation ["Inform the team of all medications, especially anticoagulants", "Pre-test genetic counselling session is mandatory"] Indications ["Patients with neurological and renal symptoms suggestive of this rare disorder", "Confirmation of clinical diagnosis", "Family screening"] Measurement technique Confirm with laboratory Codes LOINC: 93353-6 ICD-10: G31.81, N19 Clinical summary This genetic test evaluates the COX10 gene for pathogenic variants associated with mitochondrial encephalopathy and proximal renal tubulopathy.
TEST-6160 CPT1A Gene (Carnitine Palmitoyltransferase 1A Deficiency) Genetic Test This genetic test identifies pathogenic variants in the CPT1A gene, which are responsible for carnitine palmitoyltransferase 1A deficiency, a fatty acid oxidation disorder.	Whole Blood (EDTA), Buccal Swab, or DNA on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CPT1A gene variants", "Long-chain fatty acid oxidation pathway"] Parameters [] Preparation ["No fasting required", "Inform phlebotomist about anticoagulant therapy"] Indications ["Unexplained metabolic decompensation", "Family history of CPT1A deficiency", "Carrier screening", "Reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 94706-2 ICD-10: E71.314 Clinical summary This genetic test identifies pathogenic variants in the CPT1A gene, which are responsible for carnitine palmitoyltransferase 1A deficiency, a fatty acid oxidation disorder.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.